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Background: This study tests the hypotheses that health-related quality of life (HRQOL) in prevalent dialysis
patients with diabetes is lower than in dialysis patients without diabetes, and is at least as poor as diabetic patients
with another severe complication, i.e.. foot ulcers. This study also explores the mortality risk associated with
diabetes in dialysis patients.
Methods: HRQOL was assessed using the Short Form-36 Health Survey (SF-36), in a cross-sectional study of 301
prevalent dialysis patients (26% with diabetes), and compared with diabetic patients not on dialysis (n = 221),
diabetic patients with foot ulcers (n = 127), and a sample of the general population (n = 5903). Mortality risk was
assessed using a Kaplan-Meier plot and Cox proportional hazards analysis.
Results: Self-assessed vitality, general and mental health, and physical function were significantly lower in dialysis
patients with diabetes than in those without. Vitality (p = 0.011) and general health (p <0.001) was impaired in
diabetic patients receiving dialysis compared to diabetic patients with foot ulcers, but other subscales did not differ.
Diabetes was a significant predictor for mortality in dialysis patients, with a hazard ratio (HR) of 1.6 (95% CI 1.0-2.5)
after adjustment for age, dialysis vintage and coronary artery disease. Mental aspects of HRQOL were an
independent predictor of mortality in diabetic patients receiving dialysis after adjusting for age and dialysis vintage
(HR 2.2, 95% CI 1.0-5.0).
Conclusions: Physical aspects of HRQOL were perceived very low in dialysis patients with diabetes, and lower than
in other dialysis patients and diabetic patients without dialysis. Mental aspects predicted mortality in dialysis
patients with diabetes. Increased awareness and measures to assist physical function impairment may be
particularly important in diabetes patients on dialysis.
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Diabetic nephropathy has become one of the most fre-
quent causes of end-stage renal disease (ESRD) world-
wide, and an increasing number of diabetes patients
require haemodialysis or peritoneal dialysis treatment.
The incidence of diabetes patients requiring maintenance
dialysis has been rising in Norway during the last* Correspondence: ingrid.os@medisin.uio.no
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reproduction in any medium, provided the ordecade, but is still lower than what has been observed in
other parts of Europe and the U.S. [1-4]. In 2009 in
Norway, about 18% of patients undergoing dialysis had
diabetes as a comorbid condition. Diabetic nephropathy
was also the cause of ESRD in 18% of patients undergo-
ing dialysis, and the majority of these patients were type
2 diabetics [4]. The considerable rise in the number of
diabetes patients requiring dialysis is likely to increase
even further as the population is aging, the prevalence of
obesity is increasing, and survival rates after cardiovascu-
lar events have improved. Although diabetes patientsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ation, high comorbidity, especially concomitant cardio-
vascular diseases, may limit their possibilities for future
transplants.
Health-related quality of life (HRQOL) is an important
issue for both diabetes patients and dialysis patients
[5-7]. HRQOL, and in particular its physical aspects,
has been found to be a predictor of mortality in ESRD
patients receiving dialysis [8-10]. Self-reported physical
aspects of HRQOL are also a predictor for mortality in
type 2 diabetes patients without ESRD [11], and, this
finding has been extended to include elderly patients
with type 2 diabetes [12]. However, the data are scarce
and conflicting with regard to how self-perceived
physical and mental health may affect survival in
diabetes patients on dialysis [13,14]. Few studies have
compared HRQOL in dialysis patients with and without
diabetes, and those that have provide inconsistent results
[6,7,13-15]. Relating HRQOL to various subgroups may
provide important clinical information about particularly
vulnerable patients. Previously, HRQOL has been assessed
in the diabetic population in Norway, and specifically in
diabetic patients with foot ulcers [16]. The results indi-
cated that patients with diabetic foot ulcers had a lower
HRQOL, especially with regard to the physical aspects of
HRQOL, compared to the general diabetic population.
However, there have been no comparisons undertaken
between diabetes patients with severe complications such
as ESRD and those with foot ulcers.
Thus, the objectives of this study were, first, to test the
hypothesis that the HRQOL in prevalent dialysis patients
with diabetes is lower than in those patients without dia-
betes, and second, to test the hypothesis that the
HRQOL in diabetes patients undergoing dialysis is at
least as poor as in diabetes patients with foot ulcers.
Finally, we examined the mortality risk associated with
diabetes in patients on chronic dialysis.
Methods
Study patients and design
The first study objective examined prevalent dialysis
patients, and consisted of a cross-sectional cohort and a
prospective cohort, with a median follow-up time of
3.6 years. All adult patients (≥18 years) receiving haemo-
dialysis or peritoneal dialysis in 10 different dialysis units
(with a catchment area of more than two millions per-
sons) were screened for study participation. They were
eligible to be included in the study if they were in stable
condition and had received maintenance dialysis for more
than 2-months, as previously detailed [17]. Adequate
proficiency in the Norwegian language was compulsory.
Both oral and written information about the study was
provided to the patients, and a signed informed consent
was required for enrolment. The enrolment rate was72.4%, with 301 patients included (close to 1/3 of the
prevalent dialysis population in Norway). None of the
patients were lost to follow-up. Nurses and physicians
were specifically trained in applying the study instru-
ments, which consisted of self-administered question-
naires, as detailed previously [17]. The National
Committee for Medical Health Research Ethics in Nor-
way approved the study protocol, and concession was
obtained from the National Data Inspectorate. The in-
vestigation was conducted according to the Declaration
of Helsinki.
The second study objective compared the HRQOL in
three groups of diabetes patients: the group of 78 dialysis
patients with diabetes, a group of 127 diabetes patients
with foot ulcers on or below the malleoli, taken from an
anonymised database of patients treated at outpatient
clinics in the Oslo area [16], and a group of 221 diabetes
patients without complications, who had participated in
the Norwegian Survey of Level of Living in 2002. We
also had a group of 5903 persons without diabetes from
the general population [16]. The study of the diabetes
patients with foot ulcers took place five years prior to
our cross-sectional study. Data concerning the time of
renal transplantation and time of death were retrieved
from the Norwegian Renal Registry [4].
Demographic and clinical data
Demographic and clinical data from the dialysis patients,
including age and gender, were collected from reviews of
hospital charts and/or direct questioning of the patients.
The diagnosis and type of diabetes mellitus was based
on information from hospital records and laboratory
results. A dialysis patient was considered to have dia-
betes mellitus if diabetic nephropathy was the primary
cause of renal failure, or if diabetes was present as a
comorbidity. Comorbidity was assessed using the modi-
fied Charlson comorbidity index (CCI, 18) but without
age (i.e., not adding a score of 1 for each decade above
40 years). Since both diabetes and diabetic nephropathy
were included in the calculation, a separate comorbidity
score was also calculated after correcting for diabetes
and/or diabetic nephropathy. The demographic and clin-
ical data for the diabetic patients with foot ulcers has
been presented previously [16,18], and are therefore
summarised only briefly in the results section.
Assessment of HRQOL
The Kidney Disease and Quality of Life Short Form ver-
sion 1.3 (KDQOL-SF, 20) was applied to assess generic
and disease-specific HRQOL. The first part comprised
the Medical Outcome Study, a 36-item Short-Form
Health Survey (SF-36) that measures the generic dimen-
sions of HRQOL using eight subscales [19]. The physical
summary (PCS) and the mental component summary
Table 1 Clinical characteristics (given as mean [SD],
median [IQR], or percentage) in prevalent dialysis
patients (n = 301) with and without diabetes mellitus
Diabetes
mellitus, n = 78
No diabetes
mellitus, n = 223
Age years 58.9 (13,5) 60.1 (17.1)
Male gender % 68 65
Smokers 31 25
Married or cohabitant % 63 64
Body mass index kg/m2 26.1 (5.5) 24.4 (4.5)
Haemoglobin g/dL 12.4 (1.4) 12.0 (1.5)
Albumin g/L 38.2 (4.3) 38.2 (5.2)
CRP mmol/L 6.6 (2.5-15.1) 6.0 (2.1-12.7)
PTH pmol/L 32.3 (13.4-47.8) 22.9 (13.5-37.9)
Dialysis vintage years 10 (5–24) 10 (6–24)
Peritoneal dialysis % 24 18
Kt/V (haemodialysis) 1.31 (0.19) 1.38 (0.29)
Urea mmol/L 21.8 (5.5) 22.4 (6.8)
Comorbidity
Charlson comorbidity index 5.5 (1.6) 3.3 (1.3)
Nephrosclerosis % 24 37
Previous renal graft % 11 18
Diabetes type 1% 41
Diabetes type 2% 59
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rithm [20]. The kidney disease-specific portion of the
KDQOL-SF consists of 43 items classified into 11 spe-
cific kidney-related scales [21].
Statistical analyses
Descriptive data are presented either as mean ± standard
deviation (SD), or as medians with interquartile range
(IQR). Percentages are given for categorical variables.
The Student’s t-test or the Mann–Whitney test were
used for comparisons between two groups, and the
Kruskal-Wallis test or one-way analysis of variance was
performed when comparing several groups. Survival was
analysed from the time of entry into the study until
death, and also after excluding patients with shorter
observation period than 2 months. A sensitivity analysis
was also done for the mortality risk, examining patients
after they had been on dialysis > 4 months. Survival
data were not collected from patients after renal trans-
plantation. Cumulative survival curves were constructed
using the Kaplan-Meier method, with patients stratified
by the presence or absence of diabetes, and with
patients stratified for the presence or absence of kidney
disease. Survival rates were compared using the log-
rank test. Patients were stratified by PCS or MCS scores
(above or below median), and survival was analysed
using Kaplan-Meier plots. The magnitude of the asso-
ciations between diabetes and mortality risk were esti-
mated with Cox-proportional hazard models, using a
univariate model entering only diabetes as a variable,
then adjusting for age, coronary artery disease, duration
of dialysis, and either PCS or MSC. This provided a
hazard ratio (HR) with a 95% confidence interval (CI).
Since diabetes and the comorbidity score were consid-
ered substantially correlated (r = 0.63), comorbidity was
not included as a co-variable in the model; instead, the
presence or absence of coronary artery disease was
included as an important clinical variable. A one-way
analysis of variance (F-statistics) was used to test differ-
ences in the means of the subscales of SF-36 between
groups, and thereafter, post hoc multiple comparisons
using the Bonferroni test. The data were analysed using
SPSS for Windows, version 19 (SPSS, Chicago, U.S.).A
value of p ≤ 0.05 was considered significant.
Results
Clinical characteristics of the dialysis population are pro-
vided in Table 1. Dialysis patients without diabetes had a
slightly lower body mass index (p =0.013), but otherwise
did not differ from diabetes patients in this cohort. Dia-
betic nephropathy was the cause of renal failure in forty-
one (52%) of the diabetes patients undergoing dialysis.
The comorbidity scores differed between these groups,
with the highest scores in the dialysis patients withdiabetes [Table 1]. However, after removing the diabetes
and diabetic nephropathy variables, there was no longer
a significant difference in comorbidity scores between
the two groups (median 3 IQR 2–4 vs. 3, 2–4, mean
3.5 ± 1.5 and 3.3 ± 1.3).
Diabetic patients with foot ulcers and diabetic dialysis
patients did not differ in age (p = 0.3), gender (p = 0.5) or
smoking habits (p = 0.9). Body mass index was higher in
the diabetic patients with foot ulcers (28.1 ±6.2 kg/m2
vs. 26.1 ±5.5 kg/m2, p = 0.02). These groups also differed
with respect to kidney function, as none of the diabetic
patients with foot ulcers had ESRD, 49 % had normal
serum creatinine levels, and only 21% had diabetic
nephropathy.
There were also significant differences between the
diabetic and non-diabetic dialysis patients with respect
to walking disability (54 vs. 35%, χ2 = 7.9, p = 0.005), but
not with respect to the use of walking aids or wheel
chairs (31 vs. 25%, not significant [ns]). Three of the dia-
betic patients had a lower extremity amputation, com-
pared to no amputations in the non-diabetic dialysis
patients. A total of seven patients in the dialysis popula-
tion reported claudication, along with four in the dia-
betic group and three in the non-diabetic group. The
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patients did not differ between the diabetic and non-
diabetic groups (49 vs. 46%, ns), nor did the occurrence
of restless legs (49 vs. 46%, ns).Comparisons of KDQOL-SF-36 subscales between dialysis
patients with and without diabetes
Using the generic SF-36 health survey, dialysis patients
with diabetes had lower mean scores for mental health
(median 68; IQR 65–88 vs. 80; 65–88, p = 0.006), vitality
(40; 20–50 vs. 45; 29–65, p = 0.019) and general health
(50; 30–60 vs. 40; 20–50, p = 0.01) compared to non-
diabetic dialysis patients. The other subscales of the
SF-36 health survey did not differ significantly between
the groups. There was a significant difference in
MCS scores between patients with and without diabetes
(46 IQR 38–54 vs. 50 IQR 40–57, p = 0.04), and this
difference was of a similar magnitude for the PCS
scores (33 IQR 28–43 vs. 37 IQR 31–46, p = 0.051).
Social support was reduced for dialysis patients with
diabetes compared to those without diabetes (83; 50–100
vs. 83; 67–100, p = 0.019), while the other kidney-specific
quality of life scores did not differ significantly between
the dialysis groups, i.e., symptoms (72 vs. 75), effect of
kidney disease (66 vs. 69), burden of kidney disease (25
vs. 31), work status (0 vs. 0), cognitive function (87 vs.
93), quality of social interaction (80 vs. 87), sexual func-
tioning (63 vs. 75), sleep (65 vs. 62), staff encouragement
(75 vs. 88), and satisfaction with care (66 vs. 69).Comparisons of SF-36 subscales between diabetic
patients on dialysis and a sample from the general
population, and between diabetic patients with and
without foot ulcers
Dialysis patients with diabetes had a significantly lower
HRQOL than the general population [Table 2]. There
were also significant differences between the SF-36 sub-
scale scores, both for mental and physical health, in dia-
betes patients receiving dialysis compared to diabetesTable 2 Comparisons of HRQOL by SF-36 subscales (means, 9
n= 78), diabetes patients with foot ulcers (DFU, n =127), diab
the general population (GP) (n =5903)
DIAL DFU
Physical function 48 (42–55) 51 (46–57)
Role limitations (physical) 21 (13–29) 26 (19–32)
Bodily pain 56 (50–62) 55 (50–61)
General health 37 (33–42) 46 (41–50)
Vitality 39 (34–44) 47 (43–51)
Social function 63 (57–69) 67 (62–72)
Mental health 69 (64–74) 70 (67–74)
1 comparing p< 0.001 for all one-way analysis of variance.patients who were not receiving dialysis [Table 2]. The
SF-36 subscale scores for diabetes patients with foot
ulcers receiving dialysis and diabetes patients with foot
ulcers not receiving dialysis are shown in Table 2. Note
that the scores for vitality (p = 0.024) and general health
(p = 0.02) differed between the two groups [Figure 1].Mortality in dialysis patients with diabetes
The cumulative survival after censoring for renal trans-
plantation was reduced in dialysis patients with diabetes,
independent of the cause of renal failure, compared to
dialysis patients without diabetes, as seen in Figure 2
(Kaplan-Meier plot with separation after 12-months). A
total of 299 patients were included in the analysis with
34 events in the diabetic group (n = 78) and 69 events in
the non-diabetic group (n = 221). In addition separate
analysis was also done in patients with more than 2-
month observation period (n = 278). In univariate and
multivariable Cox regression models, diabetes remained
a significant predictor for mortality in this cohort of dia-
lysis patients, with HR 1.5 (95% CI 1.0-2.3, n =299) or
1.6 (1.0-2.4, n = 278) in the univariate model and HR 1.6
(1.0-2.5, n = 299) or 1.6 (1.0-2.4) after adjusting for age,
coronary artery disease, dialysis vintage, and PCS. When
substituting PCS with MSC in the multivariate model,
HR was 1.6 (1.00-2.4, n = 299) or 1.6 (1.0-2.4, n = 278).
The cumulative survival after censoring for renal trans-
plantation in patients diagnosed with diabetic nephropa-
thy was reduced compared to the rest of the dialysis
cohort. Nineteen events occurred in the diabetic nephro-
pathy group (n = 41), and 84 events occurred in the
other 256 dialysis patients, which included patients with-
out diabetic nephropathy (log rank χ2 =3.8, p = 0.051).
Dialysis patients without diabetes and a PCS score
above the median had higher cumulative survival rates
than those with lower PCS scores (log-rank test, χ2 =4.6,
p = 0.03). The cumulative survival rate did not differ in
dialysis patients with diabetes in the different PCS strata
(χ2 =1.0, p = 0.32, n = 299 or χ2 =0.7, p = 0.39. MSC score5%CI) in prevalent dialysis patients with diabetes (DIAL,
etes patients without complications (DM, n= 221), and
DM GP F-test 1 DIAL vs. DFU
71 (66–75) 87 (86–87) 233.8
55 (48–61) 77 (76–78) 141.7
63 (59–67) 74 (73–74) 39.1
57 (53–60) 76 (75–76) 189.5 <0.001
54 (49–57) 61 (61–62) 52.3 0.011
80 (76–83) 87 (86–87) 67.5
77 (74–80) 81 (80–81) 74.3
Figure 1 Boxplots of vitality score (upper panel) and general health (lower panel) in diabetes patients on dialysis (DIAL, hatched bar),
diabetes patients with foot ulcers (DFU), diabetes patients (DM), and the general population (GP)..
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with mortality in either the non-diabetic or diabetic dia-
lysis patients in a univariate analysis (χ2 =0.7, p = 0.4 and
χ2 =3.2, p = 0.07, respectively). In Cox regression model
entering unadjusted MCS HR was 1.8 (0.9-3.8) after
adjusting for age and dialysis vintage using a Cox regres-
sion model, MSC was a predictor of mortality in the dia-
lysis patients with diabetes, with an HR of 2.5 (95% CI
1.1-5.5, n = 299) or 2.2 (1.0-5.0, n = 278).
Discussion
The most important observation in this study was the
very low perceived mental and physical health in diabeticpatients on dialysis compared with the non-diabetic dia-
lysis patients. The HRQOL in these diabetic patients on
dialysis was poorer not only than patients without dia-
betes, but was also poorer than other diabetes patients
not receiving dialysis, as well as diabetes patients with
foot ulcers. The severity of complications in diabetes
patients has been shown to be associated with a lower
HRQOL [5,22]. In our study, it appears that SF-36 was
sensitive enough to differentiate between two major
complications of diabetes. Both vitality and general
health were perceived to be lower in diabetic patients on
dialysis compared to the diabetic patients with foot
ulcers. Both subscales have been recognised as suitable
Diabetes 
No diabetes 
Figure 2 Kaplan Meier plot of cumulative survival after censoring for renal transplantation in dialysis patients with diabetes (n = 78;
blue line) and without diabetes (n = 222, green line), χ2 = 4.3, p = 0.039 by log rank test..
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itations in the diabetic population with chronic kidney
disease who are not undergoing dialysis [23].
An association between diabetic foot ulcers and
advanced diabetic nephropathy has been shown [24-26],
and both of these conditions are associated with a long
duration of diabetes. Ndip et al. [26] have recently
reported that the prevalence of foot ulcers was five-fold
higher in dialysis-treated diabetes patients than in
pre-dialysis diabetes patients, calling attention to the
importance of dialysis as a risk factor for foot ulceration.
In this study, none of our dialysis patients had foot
ulcers during the collection of the baseline data. How-
ever, three of the dialysis patients, all with diabetes,
had lower extremity amputation, and significantly more
diabetic than non-diabetic dialysis patients reported
walking disability.
Diabetes patients on dialysis treatment rated particu-
larly poorly with respect to physical function and the
role limitations associated with physical functioning, a
measurement that embraces problems and restrictions
in daily activities. Our observation is in agreement with
a smaller Danish study in which diabetes patients on
dialysis had lower scores in several of the SF-36 sub-
scales compared to diabetes patients with normal kidney
function [6]. However, when comparing dialysis patientswith and without diabetes, our findings differed from
the Danish study [6], as well as a recent Polish study
[15]. Not only were physical aspects of HRQOL reduced
in diabetic patients on dialysis, but mental aspects, vital-
ity, and general health were also reduced, as compared
to the non-diabetic patients on dialysis. Reduced mental
aspects of HRQOL would be expected to reduce self-
management as well as treatment adherence [27], and
this is particularly relevant for diabetes patients on
dialysis.
Only self-perceived social support was reduced in the
diabetic compared to non-diabetic patients when asses-
sing the kidney-specific aspects of HRQOL. This may
have clinical implications, as inadequate social support
could potentially affect compliance and adherence to
therapy. Furthermore, supportive relationship is a poten-
tially controllable factor and enhanced support may be
protective with regard to mental and physical health
[28]. Social support would also be expected to increase
self-esteem, improve emotional control and enable more
successful coping. Our findings of reduced social sup-
port in diabetic patients contrast the observations made
in other studies [6,15], but the numerical difference in
social support between these groups was of greater mag-
nitude in the Danish study [6], and had a borderline sig-
nificance level of 0.06. The physical limitation caused by
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tion [29], and thus care givers should be particularly
aware of these patients’ needs.
The survival time in patients not receiving a renal
transplant was almost 12 months less in diabetic patients
compared to other dialysis patients. Using a univariate
analysis, diabetes predicted a roughly 50% increase in
the risk of death, which remained unchanged after
adjustments for age, coronary artery disease, and either
physical or mental aspects of HRQOL. As mortality rate
was highest the first 120 days after hemodialysis in the
Dialysis Outcomes and Practice Pattern Study [30], we
assessed mortality in patients not only after inclusion
in our study, more than two months after initiation of
dialysis, but also after two months observation period,
i.e. at least four months after dialysis initiation. The
risks were alike. Although the prognoses of diabetic
patients on dialysis have greatly improved during the
last few decades [3], their risk of death is still higher
than in non-diabetic dialysis patients, largely due to
cardiovascular complications. In a study of 268 dialysis
patients observed for 293 patient-years, the diabetic
patients had the highest comorbidity scores [31], and
when diabetic patients were compared to other patients
with the same comorbidity score, diabetes did not in-
fluence mortality [31].
In our study, low physical HRQOL was associated with
all-cause mortality in the non-diabetic patients on dialy-
sis, but we did not find this association in the diabetic
group. However, the patient number was low and
comorbidity was prevalent. On the other hand, a twofold
increased risk of mortality in patients with the lowest
compared to the highest MCS scores was observed in
the diabetes group after adjustment for age and dialysis
vintage, while the MCS score did not affect mortality
risk in the non-diabetic dialysis patients. In a large Japa-
nese study termed DOPPS (Dialysis Outcomes and Prac-
tice Pattern Study), the MCS score did not predict
mortality in a cohort of diabetes patients on haemodialy-
sis, while the PCS score was a predictor of mortality
[14]. The mean MCS and PCS scores of the Japanese
diabetic patients on dialysis (39 and 42 respectively) [14]
did not differ significantly from what we observed in the
present study (33 and 46, respectively), nor in the Da-
nish study [6] or in a Spanish study [13]. This longitu-
dinal, prospective, Spanish cohort study (CALVIDIA)
included 318 incident dialysis patients where 65% had
diabetes, the majority had diabetic nephropathy, and
both self-perceived mental as well as physical health
were significant independent predictors of mortality
[13]. With every 10 point decrease in the MCS score,
all-cause mortality increased by 37%, while a 10 point
decrease in PCS score was associated with 76% increase
in all-cause mortality [13]. However, the mental aspectsof HRQOL that predicted mortality in the Spanish study
were interpreted to be linked to depression rather than
to comorbidity. Since diabetic patients on dialysis had an
increased risk of mortality compared to non-diabetic
patients, the best treatment options should therefore be
offered to the high-risk diabetes patients. The integrated
care concept for dialysis patients should not only include
transplantation and survival, but also focus on HRQOL.
The majority of dialysis patients would undergo intense
dialysis if that led to improved energy level and sleep
quality, but only 1/5th even if it increased survival up to
three years [32].
The study presented here has several strengths but
also limitations. Our dialysis cohort represented close to
1/3 of the prevalent dialysis population in Norway at the
time of the study. None of the patients were lost during
follow-up, and there was very little missing data in the
questionnaires. When comparing HRQOL in dialysis
patients, a Norwegian cohort from the general popula-
tion was used. This may be important, as there are likely
differences in self-perceived health between countries.
Although the study of diabetic patients with foot ulcers
took place up to five years before the study of dialysis
patients, treatment options for diabetes, foot ulcers, and
dialysis have not changed significantly during that time
period. We do not have the time of diagnosis of diabetes
in the dialysis population. To estimate mortality risk, the
dialysis patient sample was small, and the results should
be interpreted with caution, as the statistical power is
low. However, differences in mortality risk were
observed, and were in-line with the results seen in larger
studies, suggesting to us that our findings are of great
clinical importance. The patients in our cohort did not
differ from the total dialysis population with respect to
age, gender, cause of primary kidney disease, prevalence
of coronary heart disease or diabetes (10). However, due
to the exclusion criteria in our study, only the healthiest
patients were included, and this may limit the
generalizability of the results. Our population was
mainly Caucasian, and the results may therefore not be
applicable to dialysis patients of other ethnicities.
Conclusions
We have shown that HRQOL in diabetes patients on
dialysis is perceived very low compared to other dialysis
patients, but also in comparison with diabetes patients
without known complications and patients with diabetic
foot ulcers. Mental health predicted mortality in dialysis
patients with diabetes only. There is clearly a need for
increased clinical awareness toward mental aspects of
health in the dialysis units. Furthermore, our results
emphasize the need for better cooperation beteen neph-
rologist and consultant liaison psychiatrist in order to
improve mental health for dialysis patients.
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are needed to improve HRQOL in diabetes patients on
dialysis, and whether these will also improve survival,
should be further explored. Renal transplantation would
likely improve HRQOL in diabetics and this needs to be
adressed in longitudinal studies. Not only is medical
intervention needed, but also greater focus on psycho-
social intervention of preventable factors would be
expected to improve the well-being of dialysis patients.
In addition, an increased awareness, with a focus on
physical exercise training or other measures to overcome
or assist physical function impairment should always be
considered in dialysis patients, and this seems particu-
larly important in patients with diabetes.
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